Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
23 authors.
Izabela GąskaMedical Institute, Jan Grodek State University in Sanok, 38-500 Sanok, Poland.
Aleksandra CzerwDepartment of Health Economics and Insurance, Center for the Humanities and Social Sciences of Medicine, Medical University of Warsaw, 00-581 Warsaw, Poland.ORCID 0000-0002-6189-6678
Monika PajewskaDepartment of Health Economics and Insurance, Center for the Humanities and Social Sciences of Medicine, Medical University of Warsaw, 00-581 Warsaw, Poland.ORCID 0000-0002-7735-5219
Olga PartykaDepartment of Health Economics and Insurance, Center for the Humanities and Social Sciences of Medicine, Medical University of Warsaw, 00-581 Warsaw, Poland.ORCID 0000-0001-6359-2902
Andrzej DeptałaDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0003-2640-2043
Anna Badowska-KozakiewiczDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.ORCID 0000-0002-4990-8760
Natalia CzerwStudents' Scientific Organization of Cancer Cell Biology, Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
Dominika MękalDepartment of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
Katarzyna SygitFaculty of Medicine and Health Sciences, University of Kalisz, 62-800 Kalisz, Poland.ORCID 0000-0001-7173-2266
Klaudia MalikowskaFaculty of Medicine and Health Sciences, University of Kalisz, 62-800 Kalisz, Poland.
Jarosław DrobnikDepartment of Family Medicine, Faculty of Medicine, Wroclaw Medical University, 51-141 Wroclaw, Poland.ORCID 0000-0001-5472-1485
Piotr PobrotynPulsantis Specialist and Rehabilitation Clinic Ltd., 53-238 Wroclaw, Poland.
Dorota Waśko-CzopnikDepartment of Gastroenterology, Hepatology with Inflammatory Bowel Disease Subunit, Provincial Specialist Hospital J. Gromkowskiego, 51-149 Wroclaw, Poland.ORCID 0000-0001-6648-6830
Tomasz SowińskiEndocare Medical Center, Simple Joint-Stock Company (S.J.S.C.), 50-558 Wroclaw, Poland.ORCID 0009-0000-9853-8906
Ewa BandurskaCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.
Weronika CiećkoCenter for Competence Development, Integrated Care and e-Health, Medical University of Gdansk, 80-204 Gdansk, Poland.ORCID 0000-0002-1496-1924
Elżbieta GrochansDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0002-3679-7002
Anna Maria CybulskaDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0002-6912-287X
Daria Schneider-MatykaDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.
Kamila RachubińskaDepartment of Nursing, Faculty of Health Sciences, Pomeranian Medical University in Szczecin, 71-210 Szczecin, Poland.ORCID 0000-0003-2200-3766
Petre IltchevDepartment of Management and Logistics in Healthcare, Medical University of Lodz, 90-136 Lodz, Poland.ORCID 0000-0002-6060-3247
Tomasz CzaplaDepartment of Management, Faculty of Management, University of Lodz, 90-237 Lodz, Poland.ORCID 0000-0002-8402-2236
Remigiusz KozlowskiDepartment of Management and Logistics in Healthcare, Medical University of Lodz, 90-136 Lodz, Poland.ORCID 0000-0003-2781-5341
Funding
National Institute of Public Health NIH - National Research Institute NIZP PZH-PIB/2021/1094/1056, task number 10.3
6 · The paper itself
Abstract
backgroundColorectal cancer is the third most common malignant cancer, and according to the predictions, the estimated number of new cases will grow in coming years. Therefore, an increase in the costs of the disease will increase as well. Therefore, there is a need for continuous research on the costs and the economic burden of colorectal cancer and for reviewing the research results systematically. The current paper presents a literature review regarding the state of knowledge about the costs of treatment and the economic burden of colorectal cancer.
methodsA total of 20 papers from MEDLINE database were included in the final analysis. The review is focused on the estimates of direct costs, i.e., treatment of colorectal cancer, screening after treatment, and indirect costs.
resultsthe vast majority of studies were focused on direct costs only, which clearly shows the literature gap. Metastatic colorectal cancer was the most frequent category for various treatment cost evaluation. The costs associated with the use of bevacizumab in various combinations were calculated most frequently.
conclusionsFurther summarizing review and developing a methodology for standardized comparisons is necessary, specifically addressing indirect costs.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Social Burden and Healthcare Costs of Colorectal Cancer. · full record | OpenQuestion